3D U/S Maternal Fetal Bonding in African American Women
The Impact of 3D Ultrasound on Maternal-Fetal Attachment Among African American Women
1 other identifier
interventional
144
1 country
1
Brief Summary
To determine whether 3D models of fetus' face created from 3D ultrasound will increase maternal and paternal attachment, lower stress, anxiety and depression and have improved life-style choices during pregnancy in African-American women.One-third of participants will receive 3D model and complete questionnaires, one-third will receive a picture of 3D ultrasound of their baby and complete questionnaires, and one-third will only complete the questionnaires
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
March 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMarch 24, 2022
March 1, 2022
2.8 years
March 15, 2022
March 15, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Maternal Antenatal Attachment Scale (MAAS)
The MAAS is a 19 item questionnaire measuring maternal-fetal attachment. Each item has five answer choices scored from 1 low attachment to 5 high attachment such that the total score ranges from 19 to 95. The measure also includes two subscales: (1) Quality of Attachment has 10 items with a range of 10-50 and measures the quality of the mother's attachment to her fetus. (2) Time measures the time spent in attachment mode (or intensity of preoccupation) and consists of 8 items for a range of 8 to 40. (for clarity one item included in the total score is not included in either subscale.)
5 minutes
Maternal Anxiety
7-question Generalized Anxiety Disorder questionnaire (GAD-7) will be administered
3 minutes
Maternal Depression
9-question Patient Health Questionnaire (PHQ-9) will be administered
3 minutes
Maternal Stress
11-question Pregnancy-Related Anxiety Questionnaire-Revised (PRAQ-R2) will be administered.
3 minutes
Study Arms (3)
3d printed model
ACTIVE COMPARATORMother r is given 3D printed model of fetus' face
Placebo
PLACEBO COMPARATORMother is given printed picture of 3D ultrasound of fetus
Control
NO INTERVENTIONStandard of Care
Interventions
Eligibility Criteria
You may qualify if:
- Age - Female 19-45 years of age
- Fluent in English
- African American
- Currently pregnant (between 26- and 31-weeks' gestation)
- Have normal 20-week ultrasound
You may not qualify if:
- Having received more than 3 ultrasounds prior to study
- Medical need for additional ultrasounds
- Multiple fetuses
- \> 31 weeks gestation
- Is not African American
- Is not fluent in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Creighton University
Omaha, Nebraska, 68178, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Megan Kalata, MD, MPH
Creighton University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2022
First Posted
March 24, 2022
Study Start
March 1, 2022
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
March 24, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share